These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6098803)

  • 1. A proposed therapy for the encephalopathies of Reye's syndrome and hepatic encephalopathy.
    Anderson B
    Med Hypotheses; 1984 Dec; 15(4):415-20. PubMed ID: 6098803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum gamma-aminobutyric acid levels in children with Reye's syndrome.
    Minuk GY; Sarjeant EJ; Buchan K
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):528-31. PubMed ID: 4032163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and the encephalopathy of Reye's syndrome.
    Newman SL; Faraj BA; Caplan DB; Ali FM; Camp VM; Ahmann PA
    Lancet; 1979 Nov; 2(8152):1097-100. PubMed ID: 91838
    [No Abstract]   [Full Text] [Related]  

  • 7. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
    Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C
    Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
    Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 11. Reye's syndrome.
    Trauner DA
    West J Med; 1984 Aug; 141(2):206-9. PubMed ID: 6495727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
    Basile AS; Gammal SH; Mullen KD; Jones EA; Skolnick P
    J Neurosci; 1988 Jul; 8(7):2414-21. PubMed ID: 2854841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On octanoic acid-induced hyperventilation--implications for hepatic encephalopathy and Reye's syndrome.
    Mitkov D; Toreva D; Krustev A; Kostadinova I; Jumbasova S
    Res Exp Med (Berl); 1989; 189(5):347-54. PubMed ID: 2813970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disorders mimicking Reye's syndrome.
    Chang PF; Huang SF; Hwu WL; Hou JW; Ni YH; Chang MH
    J Formos Med Assoc; 2000 Apr; 99(4):295-9. PubMed ID: 10870312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reye's syndrome: current concepts.
    Heubi JE; Partin JC; Partin JS; Schubert WK
    Hepatology; 1987; 7(1):155-64. PubMed ID: 3542776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
    Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS
    J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential hazard of therapy for Reye's syndrome with urea cycle intermediates.
    Glasgow AM
    Pediatrics; 1977 Oct; 60(4):557-8. PubMed ID: 905032
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy for Reye's syndrome.
    Mutchie KD; Burckart GJ
    Am J Hosp Pharm; 1979 Jun; 36(6):767-73. PubMed ID: 463892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
    Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephalopathy of Reye's syndrome: a review of pathogenetic hypotheses.
    DeLong GR; Glick TH
    Pediatrics; 1982 Jan; 69(1):53-63. PubMed ID: 7033913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.